title: Opinion commune de la SOGC et du CCGM sur le dépistage génétique en contexte de procréation : Mise à jour à l'intention de l'ensemble des prestataires canadiens de soins de santé maternelle et de services en procréation, à l'ère des tests offerts directement aux consommateurs.
authors.affiliation: Calgary (Alb.).
authors.forename: R Douglas
authors.initials: RD
authors.lastname: Wilson
authors.affiliation: Montréal (Qc).
authors.forename: Isabelle
authors.initials: I
authors.lastname: De Bie
authors.affiliation: Ottawa (Ont.).
authors.forename: Christine M
authors.initials: CM
authors.lastname: Armour
authors.affiliation: Montréal (Qc).
authors.forename: Richard N
authors.initials: RN
authors.lastname: Brown
authors.affiliation: London (Ont.).
authors.forename: Carla
authors.initials: C
authors.lastname: Campagnolo
authors.affiliation: Toronto (Ont.).
authors.forename: June C
authors.initials: JC
authors.lastname: Carroll
authors.affiliation: Toronto (Ont.).
authors.forename: Nan
authors.initials: N
authors.lastname: Okun
authors.affiliation: Vancouver (C.-B.).
authors.forename: Tanya
authors.initials: T
authors.lastname: Nelson
authors.affiliation: Toronto (Ont.).
authors.forename: Rhonda
authors.initials: R
authors.lastname: Zwingerman
keywords: Bloom syndrome; Canavan disease; Carrier screening; Duchenne/Becker muscular dystrophy; Fanconi anemia; Fragile X; Gaucher disease; Niemann-Pick; Tay-Sachs disease; Walker-Warburg; X-linked disorder; autosomal dominant disorder; autosomal recessive disorder; cystic fibrosis; familial dysautonomia; glycogen storage disease; hemoglobinopathy; hemophilia A; hemophilia B; invasive prenatal testing; maple syrup urine disease; mucolipidosis; perinatal autopsy; prenatal screening; spinal muscular atrophy; thalassemia